(Adds Outlook)
For the full-year, Abbott (ABT) has raised its earnings outlook.
Abbott now projects earnings per share of $3.25 - $3.40 for the full year, up from the previous outlook of $3.20 - $3.40. Excluding special items, earnings per share is now expected in the range of $4.55 - $4.70, up from $4.50 - $4.70, guided earlier.
On average, 24 analysts polled by Thomson-Reuters expect the company to report earnings of $4.59 per share for the year.
For the second quarter Abbott sees earnings per share in the range of $0.69 - $0.73. Excluding one-time items, earnings per share is expected between $1.08 and $1.12, The consensus estimate stands at $1.12.
For the first quarter, Abbott revealed earnings that decreased from last year.
The company's bottom line totaled $1.23 billion, or $0.70 per share. This compares with $1.32 billion, or $0.75 per share, in last year's first quarter.
Excluding items, Abbott Laboratories reported adjusted earnings of $1.73 billion or $0.98 per share for the period.
The company's revenue for the quarter rose 2.2% to $9.96 billion from $9.75 billion last year.
Abbott Laboratories earnings at a glance (GAAP) :
-Earnings (Q1): $1.23 Bln. vs. $1.32 Bln. last year.
-EPS (Q1): $0.70 vs. $0.75 last year.
-Revenue (Q1): $9.96 Bln vs. $9.75 Bln last year.
-Guidance:
Full year EPS guidance: $4.55 - $4.70
For comments and feedback: editorial@rttnews.com